Inflammatory disorders

Targeting necroptosis for inflammatory myopathies

A new study has suggested that treatment to target necroptosis in muscle fibers using a necroptosis inhibitor lessens myositis-induced muscle weakness as well as muscle cell death and inflammation in the muscles. This has ...

Oncology & Cancer

New therapeutic target for hematologic malignancies identified

Inhibition of Ubiquitin Specific Peptidase 47 (USP47) was identified as a novel therapeutic target for hematologic malignancies bearing mutant oncoprotein EZH2, according to scientists from the Hefei Institutes of Physical ...

Psychology & Psychiatry

Synaptic dysfunction in schizophrenia

Schizophrenia, which can cause disrupted thought and mood, delusions and hallucinations, is among the most debilitating mental disorders and the most mysterious.

Neuroscience

Pupillary light reflex can be inhibited by multisensory signals

Multisensory integration has been recently shown to produce a larger pupil size than unisensory constituents. Superior colliculus (SC), an important laminar nucleus in the midbrain, not only engages in spatial attention and ...

Oncology & Cancer

'Catch-22' scenario good news for some cancer patients

Traits that allow cancer cells to escape the body's natural defense system and develop into tumors are actually a good indicator to a patient's survival prognosis, according to University of Queensland researchers.

Medical research

Metabolic response behind reduced cancer cell growth

Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells' ...

page 2 from 13